Altered expression of androgen-receptor isoforms in human colon-cancer tissues. 2000

M G Catalano, and U Pfeffer, and M Raineri, and P Ferro, and A Curto, and P Capuzzi, and F Corno, and L Berta, and N Fortunati
Endocrinology Laboratory, II UOADU General Medicine, Azienda Ospedaliera S. Giovanni Battista and University of Turin, Turin, Italy.

Many groups have examined of androgen the effects on normal and neoplastic colon tissues, but no clear picture has hitherto emerged. In particular, the presence and the function of the androgen receptor (AR) has only partially been investigated in the past. The present study reports analysis of expression of the AR gene as messenger RNA and as protein in surgical samples of neoplastic colon mucosa and of corresponding healthy surrounding tissue. Specific binding for DHT, demonstrating the presence of AR, was observed in almost all the samples (2 samples out of 12 were negative). No significant difference was observed between healthy and neoplastic mucosa, or between male and female patients. A further characterization of AR was performed with Western blot, using 2 different primary antibodies. Both AR isoforms, AR-B and AR-A, were detected in healthy mucosa, while only AR-A, resolving at 87 kDa, was observed in neoplastic mucosa. RT-PCR analysis revealed the transcript for AR in both healthy and neoplastic mucosa in 10 samples; no message was detectable in 2 samples (negative also for binding); 2 additional samples presented AR mRNA only in healthy colon mucosa, 2 others only in neoplastic mucosa. In addition, a variant AR messenger RNA, probabily derived from alternative splicing, was observed. We found that AR is expressed both in healthy and in neoplastic colon mucosa, either as mRNA or as protein. Neoplastic colon tissue shows a characteristic loss of expression of the AR-B isoform, while AR-A expression is maintained. These findings underscore the possible role of androgen and its receptor in colon carcinogenesis.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011944 Receptors, Androgen Proteins, generally found in the CYTOPLASM, that specifically bind ANDROGENS and mediate their cellular actions. The complex of the androgen and receptor migrates to the CELL NUCLEUS where it induces transcription of specific segments of DNA. Androgen Receptors,5 alpha-Dihydrotestosterone Receptor,Androgen Receptor,Dihydrotestosterone Receptors,Receptor, Testosterone,Receptors, Androgens,Receptors, Dihydrotestosterone,Receptors, Stanolone,Stanolone Receptor,Testosterone Receptor,5 alpha Dihydrotestosterone Receptor,Androgens Receptors,Receptor, 5 alpha-Dihydrotestosterone,Receptor, Androgen,Receptor, Stanolone,Stanolone Receptors,alpha-Dihydrotestosterone Receptor, 5
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000728 Androgens Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power. Androgen,Androgen Receptor Agonist,Androgen Effect,Androgen Effects,Androgen Receptor Agonists,Androgenic Agents,Androgenic Compounds,Agents, Androgenic,Agonist, Androgen Receptor,Agonists, Androgen Receptor,Compounds, Androgenic,Effect, Androgen,Effects, Androgen,Receptor Agonist, Androgen,Receptor Agonists, Androgen
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D015179 Colorectal Neoplasms Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI. Colorectal Cancer,Colorectal Carcinoma,Colorectal Tumors,Neoplasms, Colorectal,Cancer, Colorectal,Cancers, Colorectal,Carcinoma, Colorectal,Carcinomas, Colorectal,Colorectal Cancers,Colorectal Carcinomas,Colorectal Neoplasm,Colorectal Tumor,Neoplasm, Colorectal,Tumor, Colorectal,Tumors, Colorectal

Related Publications

M G Catalano, and U Pfeffer, and M Raineri, and P Ferro, and A Curto, and P Capuzzi, and F Corno, and L Berta, and N Fortunati
October 2003, Zhonghua nan ke xue = National journal of andrology,
M G Catalano, and U Pfeffer, and M Raineri, and P Ferro, and A Curto, and P Capuzzi, and F Corno, and L Berta, and N Fortunati
January 2011, PloS one,
M G Catalano, and U Pfeffer, and M Raineri, and P Ferro, and A Curto, and P Capuzzi, and F Corno, and L Berta, and N Fortunati
July 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society,
M G Catalano, and U Pfeffer, and M Raineri, and P Ferro, and A Curto, and P Capuzzi, and F Corno, and L Berta, and N Fortunati
February 2002, Breast cancer research and treatment,
M G Catalano, and U Pfeffer, and M Raineri, and P Ferro, and A Curto, and P Capuzzi, and F Corno, and L Berta, and N Fortunati
December 2001, Zhonghua yi xue za zhi,
M G Catalano, and U Pfeffer, and M Raineri, and P Ferro, and A Curto, and P Capuzzi, and F Corno, and L Berta, and N Fortunati
January 1997, European urology,
M G Catalano, and U Pfeffer, and M Raineri, and P Ferro, and A Curto, and P Capuzzi, and F Corno, and L Berta, and N Fortunati
January 2018, PloS one,
M G Catalano, and U Pfeffer, and M Raineri, and P Ferro, and A Curto, and P Capuzzi, and F Corno, and L Berta, and N Fortunati
January 2004, Cancer biology & therapy,
M G Catalano, and U Pfeffer, and M Raineri, and P Ferro, and A Curto, and P Capuzzi, and F Corno, and L Berta, and N Fortunati
December 2000, Asian journal of andrology,
M G Catalano, and U Pfeffer, and M Raineri, and P Ferro, and A Curto, and P Capuzzi, and F Corno, and L Berta, and N Fortunati
January 2001, Cancer research,
Copied contents to your clipboard!